This provides some credence to one model of MPNST oncogenesis, which primarily involves a combination of RAS deregulation and epigenetic dysregulation, due to lesions in NF1 and PRC2, respectively. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.